SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '8E6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_A_NCAA700_0 (EXOTOXIN A)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	5 / 7	HIS A 201 GLY A 202 TYR A 235 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.46A	1dmaA-5xstA: 6.0	1dmaA-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_B_NCAB700_0 (EXOTOXIN A)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 6	HIS A 201 GLY A 202 TYR A 235 ALA A 237 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.38A	1dmaB-5xstA: 6.1	1dmaB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS8_A_BRLA503_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	5 / 12	GLY A 210 ILE A 234 HIS A 201 LEU A 259 LEU A 338	None None 8E6 A 401 (-3.5A) None None	1.20A	3cs8A-5xstA: undetectable	3cs8A-5xstA: 15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 ALA A 237 LYS A 242 SER A 243 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.9A)	1.33A	3u9hA-5xstA: 19.1	3u9hA-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 ALA A 237 SER A 243 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.83A	3u9hA-5xstA: 19.1	3u9hA-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 LYS A 242 SER A 243	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A)	0.93A	3u9hA-5xstA: 19.1	3u9hA-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 SER A 243 TYR A 246	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A)	0.37A	3u9hA-5xstA: 19.1	3u9hA-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 ALA A 237 LYS A 242 SER A 243 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.9A)	1.33A	3u9hB-5xstA: 19.1	3u9hB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 ALA A 237 SER A 243 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.80A	3u9hB-5xstA: 19.1	3u9hB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 LYS A 242 SER A 243	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A)	0.97A	3u9hB-5xstA: 19.1	3u9hB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 SER A 243 TYR A 246	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A)	0.42A	3u9hB-5xstA: 19.1	3u9hB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	5 / 6	HIS A 201 GLY A 202 TYR A 235 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.57A	4ae1A-5xstA: 6.6	4ae1A-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	5 / 5	HIS A 201 GLY A 202 TYR A 235 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.58A	4ae1B-5xstA: 6.1	4ae1B-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 ALA A 237 LYS A 242 SER A 243 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.9A)	1.32A	4bjcA-5xstA: 18.4	4bjcA-5xstA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 ALA A 237 SER A 243 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.77A	4bjcA-5xstA: 18.4	4bjcA-5xstA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 LYS A 242 SER A 243	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A)	0.94A	4bjcA-5xstA: 18.4	4bjcA-5xstA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	6 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 SER A 243 TYR A 246	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A)	0.35A	4bjcA-5xstA: 18.4	4bjcA-5xstA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_A_NCAA1201_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	7 / 7	HIS A 201 GLY A 202 TYR A 235 ALA A 237 SER A 243 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.58A	4hyfA-5xstA: 20.1	4hyfA-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_B_NCAB1201_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	7 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 LYS A 242 SER A 243 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.9A)	0.88A	4hyfB-5xstA: 20.3	4hyfB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_B_NCAB1201_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	7 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 SER A 243 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.59A	4hyfB-5xstA: 20.3	4hyfB-5xstA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_C_NCAC1201_0 (TANKYRASE-2)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	8 / 8	HIS A 201 GLY A 202 TYR A 235 ALA A 237 LYS A 242 SER A 243 TYR A 246 GLU A 327	8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.56A	4hyfC-5xstA: 20.3	4hyfC-5xstA: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	10 / 11	GLN A 98 GLU A 102 HIS A 201 GLY A 202 TYR A 228 TYR A 235 ALA A 237 LYS A 242 TYR A 246 GLU A 327	8E6 A 401 ( 4.7A) 8E6 A 401 (-4.2A) 8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.7A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.74A	4rv6A-5xstA: 52.5	4rv6A-5xstA: 98.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	10 / 11	GLN A 98 GLU A 102 HIS A 201 GLY A 202 TYR A 235 ALA A 237 LYS A 242 SER A 243 TYR A 246 GLU A 327	8E6 A 401 ( 4.7A) 8E6 A 401 (-4.2A) 8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.62A	4rv6A-5xstA: 52.5	4rv6A-5xstA: 98.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	11 / 11	GLN A 98 GLU A 102 HIS A 201 GLY A 202 TYR A 228 TYR A 235 ALA A 237 LYS A 242 SER A 243 TYR A 246 GLU A 327	8E6 A 401 ( 4.7A) 8E6 A 401 (-4.2A) 8E6 A 401 (-3.5A) 8E6 A 401 (-3.9A) 8E6 A 401 (-3.7A) 8E6 A 401 (-4.1A) 8E6 A 401 (-3.5A) 8E6 A 401 (-4.3A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A) 8E6 A 401 (-3.9A)	0.72A	4rv6B-5xstA: 52.7	4rv6B-5xstA: 98.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	8 / 9	GLU A 102 ASP A 109 HIS A 201 SER A 203 ASN A 207 ILE A 211 SER A 243 TYR A 246	8E6 A 401 (-4.2A) None 8E6 A 401 (-3.5A) None None None 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A)	0.80A	5ha9B-5xstA: 49.2	5ha9B-5xstA: 98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5xst	POLY [ADP-RIBOSE] POLYMERASE 1 (Homo sapiens)	7 / 9	HIS A 201 SER A 203 ASN A 207 ILE A 211 TYR A 235 SER A 243 TYR A 246	8E6 A 401 (-3.5A) None None None 8E6 A 401 (-4.1A) 8E6 A 401 (-2.6A) 8E6 A 401 (-3.4A)	0.51A	5ha9B-5xstA: 49.2	5ha9B-5xstA: 98.75

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DMA_A_NCAA700_0","EXOTOXIN A","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",5,"HIS A 201;GLY A 202;TYR A 235;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.46A","1dmaA-5xstA:6.0",null],["1DMA_B_NCAB700_0","EXOTOXIN A","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.38A","1dmaB-5xstA:6.1","1dmaA-5xstA:undetectable"],["3CS8_A_BRLA503_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",5,"GLY A 210;ILE A 234;HIS A 201;LEU A 259;LEU A 338","None;None;8E6 A 401 (-3.5A);None;None","1.20A","3cs8A-5xstA:undetectable","1dmaB-5xstA:undetectable"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;ALA A 237;LYS A 242;SER A 243;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.9A)","1.33A","3u9hA-5xstA:19.1","3cs8A-5xstA:15.35"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;ALA A 237;SER A 243;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.83A","3u9hA-5xstA:19.1","3u9hA-5xstA:undetectable"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;LYS A 242;SER A 243","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A)","0.93A","3u9hA-5xstA:19.1","3u9hA-5xstA:undetectable"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;SER A 243;TYR A 246","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A)","0.37A","3u9hA-5xstA:19.1","3u9hA-5xstA:undetectable"],["3U9H_B_NCAB1164_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;ALA A 237;LYS A 242;SER A 243;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.9A)","1.33A","3u9hB-5xstA:19.1","3u9hA-5xstA:undetectable"],["3U9H_B_NCAB1164_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;ALA A 237;SER A 243;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.80A","3u9hB-5xstA:19.1","3u9hB-5xstA:undetectable"],["3U9H_B_NCAB1164_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;LYS A 242;SER A 243","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A)","0.97A","3u9hB-5xstA:19.1","3u9hB-5xstA:undetectable"],["3U9H_B_NCAB1164_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;SER A 243;TYR A 246","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A)","0.42A","3u9hB-5xstA:19.1","3u9hB-5xstA:undetectable"],["4AE1_A_NCAA1536_0","DIPHTHERIA TOXIN","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",5,"HIS A 201;GLY A 202;TYR A 235;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.57A","4ae1A-5xstA:6.6","3u9hB-5xstA:undetectable"],["4AE1_B_NCAB1536_0","DIPHTHERIA TOXIN","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",5,"HIS A 201;GLY A 202;TYR A 235;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.58A","4ae1B-5xstA:6.1","4ae1A-5xstA:undetectable"],["4BJC_A_RPBA2162_1","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;ALA A 237;LYS A 242;SER A 243;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.9A)","1.32A","4bjcA-5xstA:18.4","4ae1B-5xstA:undetectable"],["4BJC_A_RPBA2162_1","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;ALA A 237;SER A 243;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.77A","4bjcA-5xstA:18.4","4bjcA-5xstA:15.62"],["4BJC_A_RPBA2162_1","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;LYS A 242;SER A 243","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A)","0.94A","4bjcA-5xstA:18.4","4bjcA-5xstA:15.62"],["4BJC_A_RPBA2162_1","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",6,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;SER A 243;TYR A 246","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A)","0.35A","4bjcA-5xstA:18.4","4bjcA-5xstA:15.62"],["4HYF_A_NCAA1201_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",7,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;SER A 243;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.58A","4hyfA-5xstA:20.1","4bjcA-5xstA:15.62"],["4HYF_B_NCAB1201_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",7,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;LYS A 242;SER A 243;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.9A)","0.88A","4hyfB-5xstA:20.3","4hyfA-5xstA:undetectable"],["4HYF_B_NCAB1201_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",7,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;SER A 243;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.59A","4hyfB-5xstA:20.3","4hyfB-5xstA:undetectable"],["4HYF_C_NCAC1201_0","TANKYRASE-2","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",8,"HIS A 201;GLY A 202;TYR A 235;ALA A 237;LYS A 242;SER A 243;TYR A 246;GLU A 327","8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.56A","4hyfC-5xstA:20.3","4hyfB-5xstA:undetectable"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",10,"GLN A  98;GLU A 102;HIS A 201;GLY A 202;TYR A 228;TYR A 235;ALA A 237;LYS A 242;TYR A 246;GLU A 327","8E6 A 401 ( 4.7A);8E6 A 401 (-4.2A);8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.7A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.74A","4rv6A-5xstA:52.5","4hyfC-5xstA:undetectable"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",10,"GLN A  98;GLU A 102;HIS A 201;GLY A 202;TYR A 235;ALA A 237;LYS A 242;SER A 243;TYR A 246;GLU A 327","8E6 A 401 ( 4.7A);8E6 A 401 (-4.2A);8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.62A","4rv6A-5xstA:52.5","4rv6A-5xstA:98.77"],["4RV6_B_RPBB1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",11,"GLN A  98;GLU A 102;HIS A 201;GLY A 202;TYR A 228;TYR A 235;ALA A 237;LYS A 242;SER A 243;TYR A 246;GLU A 327","8E6 A 401 ( 4.7A);8E6 A 401 (-4.2A);8E6 A 401 (-3.5A);8E6 A 401 (-3.9A);8E6 A 401 (-3.7A);8E6 A 401 (-4.1A);8E6 A 401 (-3.5A);8E6 A 401 (-4.3A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A);8E6 A 401 (-3.9A)","0.72A","4rv6B-5xstA:52.7","4rv6A-5xstA:98.77"],["5HA9_B_TP0B406_1","POLY [ADP-RIBOSE] POLYMERASE 1","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",8,"GLU A 102;ASP A 109;HIS A 201;SER A 203;ASN A 207;ILE A 211;SER A 243;TYR A 246","8E6 A 401 (-4.2A);None;8E6 A 401 (-3.5A);None;None;None;8E6 A 401 (-2.6A);8E6 A 401 (-3.4A)","0.80A","5ha9B-5xstA:49.2","4rv6B-5xstA:98.77"],["5HA9_B_TP0B406_1","POLY [ADP-RIBOSE] POLYMERASE 1","5xst","POLY [ADP-RIBOSE] POLYMERASE 1","Homo sapiens",7,"HIS A 201;SER A 203;ASN A 207;ILE A 211;TYR A 235;SER A 243;TYR A 246","8E6 A 401 (-3.5A);None;None;None;8E6 A 401 (-4.1A);8E6 A 401 (-2.6A);8E6 A 401 (-3.4A)","0.51A","5ha9B-5xstA:49.2","5ha9B-5xstA:98.75"]]